A phase 3, randomized, open-label, multi-center clinical study to observe the efficacy and safety of TMX-67 compared to allopurinol in patients with a malignant tumor receiving chemotherapy
Latest Information Update: 24 May 2016
At a glance
- Drugs Febuxostat (Primary) ; Allopurinol
- Indications Tumour lysis syndrome
- Focus Registrational; Therapeutic Use
- Sponsors Teijin Pharma
- 24 Jan 2014 New trial record